NovaBridge Biosciences NBP
NASDAQ NBP
$1.34 -0.02 (-1.83%)
As of: Oct 1, 2026 · 11:32 AM EDT

NovaBridge Biosciences (NBP) Cash from Operations (2019 - 2025)

Updated

NovaBridge Biosciences (NBP) reported Cash from Operations of -$14.6 million for Q4 2025, compared with -$10.95 million a year earlier.

Analysis

NovaBridge Biosciences (NBP) Cash from Operations (2019 - 2025) Analysis & Trends

For FY2025, NovaBridge Biosciences posted Cash from Operations of -$20.6 million.

  • By year, Cash from Operations came in at -$52.67 million in FY2024, -$72.7 million in FY2023, -$49.58 million in FY2022 and -$152.7 million in FY2021.
  • The Q4 2025 figure ranks as the lowest quarterly Cash from Operations since Q4 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 8.62 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 3.44 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 5.37 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.88 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 4.58 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 4.00 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 3.57 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 835.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.13 Bn
10 NovaBridge Biosciences 150.88 Mn 150.88 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -14.60 Mn
Sep 30, 2025 1.84 Mn
Dec 31, 2024 -10.95 Mn
Sep 30, 2024 8.42 Mn
Dec 31, 2020 153.34 Mn
Dec 31, 2019 -30.64 Mn
API Access

NovaBridge Biosciences Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=NBP&period=max&api_key=YOUR_API_KEY